Cash Flow Statement
Growth Metrics

Fortress Biotech (FBIO) Income from Non-Controlling Interests (2016 - 2025)

Fortress Biotech has reported Income from Non-Controlling Interests over the past 11 years, most recently at $78.0 million for Q4 2025.

  • Quarterly results put Income from Non-Controlling Interests at $78.0 million for Q4 2025, up 298.98% from a year ago — trailing twelve months through Dec 2025 was $39.7 million (up 567671.43% YoY), and the annual figure for FY2025 was $39.7 million, down 46.93%.
  • Income from Non-Controlling Interests for Q4 2025 was $78.0 million at Fortress Biotech, up from $3.0 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for FBIO hit a ceiling of $78.0 million in Q4 2025 and a floor of -$36.9 million in Q4 2021.
  • Median Income from Non-Controlling Interests over the past 5 years was $4.3 million (2023), compared with a mean of $4.8 million.
  • Biggest five-year swings in Income from Non-Controlling Interests: tumbled 343.48% in 2024 and later skyrocketed 298.98% in 2025.
  • Fortress Biotech's Income from Non-Controlling Interests stood at -$36.9 million in 2021, then skyrocketed by 182.55% to $30.5 million in 2022, then crashed by 35.39% to $19.7 million in 2023, then fell by 0.79% to $19.6 million in 2024, then skyrocketed by 298.98% to $78.0 million in 2025.
  • The last three reported values for Income from Non-Controlling Interests were $78.0 million (Q4 2025), $3.0 million (Q3 2025), and -$27.1 million (Q2 2025) per Business Quant data.